On Friday, Shares of Rite Aid Corporation (NYSE:RAD), gained 0.44% to $9.08.
Rite Aid Corporation declared that all of the Company’s nearly 4,600 stores nationwide will start accepting mobile payments, counting Apple PayTM and Google Wallet TM, starting Saturday, August 15. The Company will also accept Google’s forthcoming Android Pay TM. Additionally, all Rite Aid stores will also accept tap and pay credit and debit cards.
“Increasingly, consumers are actively seeking out and incorporating mobile technology into many facets of their life, counting their shopping and purchasing decisions,” said Ken Martindale, CEO of Rite Aid stores and president of Rite Aid Corporation. “By accepting mobile payments, we’re able to offer Rite Aid customers an easy and convenient checkout process, which we know is important to them. Investing in mobile technologies is just one piece of Rite Aid’s evolving digital strategy and we will continue to explore, test and implement innovative technologies that will assist us to better serve our valued customers.”
Rite Aid Corporation, through its auxiliaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, counting over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.
Shares of Medical Properties Trust Inc. (NYSE:MPW), inclined 1.51% to $12.10, during its last trading session.
Medical Properties Trust, declared that the formerly declared public offering of €500 million aggregate principal amount of senior notes due 2022 (the “Notes”) by its operating partnership, MPT Operating Partnership, L.P. (the “Operating Partnership”), and MPT Finance Corporation, a wholly-owned partner of the Operating Partnership (“MPT Finance”), priced recently with a coupon of 4.00%. The Notes will be senior unsecured obligations of the Operating Partnership and MPT Finance, guaranteed by the Company.
The Operating Partnership intends to use the net proceeds from the offering of the Notes to finance the remaining aggregate purchase price payable in connection with its formerly declared acquisition of up to 35 healthcare facilities from the Median Kliniken group S.à r.l. (“MEDIAN”) and related financing and sale-leaseback transactions, to fund its formerly declared investments in Italy and Spain, to repay borrowings made under its revolving credit facility and to pay fees and expenses related to the foregoing.
Goldman, Sachs & Co., Crédit Agricole CIB, Credit Suisse Securities (Europe) Limited, J.P. Morgan, BofA Merrill Lynch and Barclays are acting as joint book running managers for the offering of the Notes; Banco Bilbao Vizcaya Argentaria, S.A., KeyBanc Capital Markets, RBC Capital Markets, Stifel, SunTrust Robinson Humphrey and Wells Fargo Securities are acting as co-lead managers.
Medical Properties Trust, Inc. operates as a real estate investment trust (REIT) in the United States. It acquires, develops, and invests in healthcare facilities; and leases healthcare facilities to healthcare operating companies and healthcare providers.
Finally, Jarden Corp. (NYSE:JAH), ended its last trade with 1.22% gain, and closed at $54.79.
Jarden Corp., declared that it has accomplished its acquisition of Waddington Group, Inc. (“Waddington”), a leading manufacturer and marketer of premium disposable tableware for commercial, foodservice and retail markets, from an investment fund managed by Olympus Partners, a private equity firm, and other stockholders for about $1.35 billion, subject to working capital and other adjustments. As part of the acquisition financing, on July 30th, Jarden closed on $900 million of senior secured term loans comprised of a $300 million add-on to its B-1 facility, which matures in 2020, and a new B-2 facility tranche with a principal amount of $600 million, which matures in 2022. Jarden funded the acquisition with the proceeds from its recently accomplished common stock offering and proceeds from the aforementioned term loan financings.
Barclays Bank PLC acted as Administrative Agent on the $900 million senior secured term loan B-1 and B-2 facilities. Barclays Bank PLC, Credit Suisse Securities (USA) LLC, and UBS Securities LLC were Joint Lead Arrangers and Bookrunners on the facilities. Additionally, Barclays Capital Inc., Credit Suisse Securities (USA) LLC, and UBS Securities LLC acted as lead book-running managers for the recent common stock offering. Greenberg Traurig, LLP acted as legal counsel to Jarden on the acquisition.
Jarden Corporation manufactures, markets, and distributes consumer products worldwide. The company’s Outdoor Solutions segment offers camping and outdoor equipment; fishing and team sports equipment; alpine and nordic skiing, snowboarding, snowshoeing, and in-line skating products; technical and outdoor apparel and equipment; personal flotation devices, water sports equipment, and all-terrain vehicle gears; and inflatable air beds and accessories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.